Clinical Trial Update: Effect of Early Use of Caffeine Citrate in Preterm Neonates [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the early use of caffeine citrate in preterm neonates has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Caffeine citrate (caffeine citrate)

Snippet

Sponsor: Ain Shams University | Conditions: Preterm Birth | Phase 3 | Status: COMPLETED